Health care workers at Baylor Scott and White Hillcrest are seeing an abundance of patients come in with mainly upper respiratory infections, flu, and COVID. Baylor Scott and White Hillcrest Emergency ...
Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug ... "best-in-class potential" for the drug, which Sanofi licensed from ...